Evidence map›Paper›PMID 37100227›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2023

A Deep Learning Approach for Histology-Based Nucleus Segmentation and Tumor Microenvironment Characterization.

Ruichen Rong, Hudanyun Sheng, Kevin W Jin, Fangjiang Wu, Danni Luo, Zhuoyu Wen, Chen Tang, Donghan M Yang, Liwei Jia, Mohamed Amgad and 5 more

Abstract read
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. SScientific reports · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ruichen RongQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.
Hudanyun ShengQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.
Kevin W JinQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.
Fangjiang WuQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.
Danni LuoQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.
Zhuoyu WenQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.
Chen TangQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.
Donghan M YangQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.
Liwei JiaDepartment of Pathology, UT Southwestern Medical Center, Dallas, Texas.
Mohamed AmgadDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Lee A D CooperDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Yang XieQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas; Department of Bioinformatics, UT Southwestern Medical Center, Dallas, Texas; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
Xiaowei ZhanQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas; Department of Bioinformatics, UT Southwestern Medical Center, Dallas, Texas; Center for the Genetics of Host Defense, UT Southwestern Medical Center, Dallas, Texas. Electronic address: Xiaowei.Zhan@utsouthwestern.edu.
Shidan WangQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas. Electronic address: Shidan.Wang@utsouthwestern.edu.
Guanghua XiaoQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas; Department of Bioinformatics, UT Southwestern Medical Center, Dallas, Texas; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas. Electronic address: Guanghua.Xiao@utsouthwestern.edu.

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V. · 1996 to 2024
$57.4M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant DisordersR01DE030656 · NIDCR · YALE UNIVERSITY · PI PICKERING, CURTIS, XIAO, GUANGHUA · 2021 to 2025
$3.4M
Finding the optimal balance of immunotherapy efficacy and toxicity.U01AI156189 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GERBER, DAVID ERIC, WAKELAND, EDWARD K. · 2020 to 2024
$3.1M
Novel computational approaches to predict drug response and combination effectsR35GM136375 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2020 to 2024
$2.0M
Developing computational algorithms for histopathological image analysisR01GM140012 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2021 to 2024
$1.6M
Informatics Tools To Analyze And Model Whole Slide Image Data At The Single Cell LevelU01CA249245 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2021 to 2023
$1.5M
Developing novel algorithms for spatial molecular profiling technologiesR01GM141519 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2021 to 2024
$1.4M
NCI NIH HHS P30 CA142543NCI NIH HHS P50 CA070907NCI NIH HHS U01 CA249245NIAID NIH HHS U01 AI156189NIDCR NIH HHS R01 DE030656NIGMS NIH HHS R01 GM140012NIGMS NIH HHS R01 GM141519NIGMS NIH HHS R35 GM136375
6 · The paper itself

Abstract

Microscopic examination of pathology slides is essential to disease diagnosis and biomedical research. However, traditional manual examination of tissue slides is laborious and subjective. Tumor whole-slide image (WSI) scanning is becoming part of routine clinical procedures and produces massive data that capture tumor histologic details at high resolution. Furthermore, the rapid development of deep learning algorithms has significantly increased the efficiency and accuracy of pathology image analysis. In light of this progress, digital pathology is fast becoming a powerful tool to assist pathologists. Studying tumor tissue and its surrounding microenvironment provides critical insight into tumor initiation, progression, metastasis, and potential therapeutic targets. Nucleus segmentation and classification are critical to pathology image analysis, especially in characterizing and quantifying the tumor microenvironment (TME). Computational algorithms have been developed for nucleus segmentation and TME quantification within image patches. However, existing algorithms are computationally intensive and time consuming for WSI analysis. This study presents Histology-based Detection using Yolo (HD-Yolo), a new method that significantly accelerates nucleus segmentation and TME quantification. We demonstrate that HD-Yolo outperforms existing WSI analysis methods in nucleus detection, classification accuracy, and computation time. We validated the advantages of the system on 3 different tissue types: lung cancer, liver cancer, and breast cancer. For breast cancer, nucleus features by HD-Yolo were more prognostically significant than both the estrogen receptor status by immunohistochemistry and the progesterone receptor status by immunohistochemistry. The WSI analysis pipeline and a real-time nucleus segmentation viewer are available at https://github.com/impromptuRong/hd_wsi.

Indexed as

Breast NeoplasmsDeep LearningAlgorithmsFemaleHumansImage Processing, Computer-AssistedTumor Microenvironmentdigital pathologynucleus segmentationwhole-slide imagingYolo

Identifiers

PMID37100227
PMCPMC11161202

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.